Adult Onset Still's Disease
Affecting the entire body, Adult Onset Still's disease (AOSD) is a rare type of inflammatory arthritis that affects most people before the age of 45.
The symptoms of the disease usually begin with a high fever that spikes once or twice a day, along with the development of a salmon-pink rash on the trunk, arms, or legs.
Recently, the AOSD market welcomed it is the first ever the USFDA approved therapy. Know more about the AOSD market, treatment guidelines, and recent approvals through our newsletter.
DelveInsight's newsletter provides rich insights into the disease overview, causes, symptoms, and diagnostic methodologies. The newsletter also covers pipeline therapies, key companies, significant collaborations, licensing opportunities, and conferences that are taking place in the field.
Gain access to the newsletter for rich, precise, and accurate AOSD market insights by filling up a simple form towards the right.
Join DelveInsight's mailer list and get all the updates and recent happenings in the Life Science vertical delivered right in your inbox.
Know more about What's covered:
- Indication overview
- Epidemiological trends
- Treatment approaches
- Key Companies
- Pipeline drugs
- Collaborations and deals in the domain
- R&D in the field
- Top conferences
- Support from International organizations
-Agonist.png)
